Press Releases
December 6, 2019
CytomX Therapeutics Announces New Employment Inducement Grants
Additional Formats
November 11, 2019
CytomX Therapeutics to Present at Upcoming Healthcare Conferences
Additional Formats
November 7, 2019
CytomX Therapeutics Announces Third Quarter 2019 Financial Results and Provides Business Update
Additional Formats
October 29, 2019
CytomX Therapeutics Announces Initiation of Phase 2 Clinical Trial Evaluating the Anti-PD-L1 Probody CX-072 in Combination with YERVOY® in Patients with Relapsed or Refractory Melanoma
Additional Formats
October 24, 2019
CytomX Therapeutics to Announce Third Quarter 2019 Financial Results
Additional Formats
October 18, 2019
CytomX Therapeutics Announces New Employment Inducement Grants
Additional Formats
October 14, 2019
CytomX Therapeutics Announces Appointment of Amy C. Peterson, M.D. as Chief Development Officer
Additional Formats
August 28, 2019
CytomX Therapeutics to Present at Upcoming Healthcare Conferences
Additional Formats
August 7, 2019
CytomX Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update
Additional Formats
August 6, 2019
CytomX Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference
Additional Formats
Displaying 1 - 10 of 29